Pcj Investment Counsel Ltd. Bausch Health Companies Inc. Transaction History

Pcj Investment Counsel Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$21.6 - $27.79 $400,464 - $515,226	-18,540 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$23.0 - $29.01 $14,030 - $17,696	-610 Reduced 3.19%	18,540 $513,000
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $1.06 Million - $1.27 Million	-42,310 Reduced 68.84%	19,150 $533,000
Q2 2021 Aug 02, 2021	BUY	$27.43 - $32.7 $744,450 - $887,478	27,140 Added 79.08%	61,460 $1.8 Million
Q1 2021 Apr 30, 2021	BUY	$21.37 - $34.38 $733,418 - $1.18 Million	34,320 New	34,320 $1.09 Million

Q1 2020 May 13, 2020	SELL	$12.98 - $30.25 $842,921 - $1.96 Million	-64,940 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$18.89 - $31.89 $675,128 - $1.14 Million	35,740 Added 122.4%	64,940 $1.95 Million
Q3 2019 Nov 13, 2019	SELL	$20.88 - $25.66 $3.79 Million - $4.66 Million	-181,520 Reduced 86.14%	29,200 $637,000
Q2 2019 Aug 07, 2019	SELL	$20.52 - $26.45 $5.17 Million - $6.66 Million	-251,770 Reduced 54.44%	210,720 $5.33 Million
Q1 2019 May 08, 2019	BUY	$20.23 - $26.29 $9.36 Million - $12.2 Million	462,490 New	462,490 $11.4 Million

281

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.57B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Pcj Investment Counsel Ltd., based on Form 13F filings with the SEC.

Stay updated on Pcj Investment Counsel Ltd. with notifications on news.